CA125: Megadaltons of novel opportunities
- 31 March 2007
- journal article
- editorial
- Published by Elsevier in Gynecologic Oncology
- Vol. 104 (3) , 505-507
- https://doi.org/10.1016/j.ygyno.2007.01.035
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patientsGynecologic Oncology, 2007
- Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumorsMolecular Cancer, 2006
- Potent suppression of natural killer cell response mediated by the ovarian tumor marker CA125Gynecologic Oncology, 2005
- Potential markers that complement expression of CA125 in epithelial ovarian cancerGynecologic Oncology, 2005
- Randomized, Placebo-Controlled Study of Oregovomab for Consolidation of Clinical Remission in Patients With Advanced Ovarian CancerJournal of Clinical Oncology, 2004
- Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian CancerNew England Journal of Medicine, 2003
- Molecular Cloning of the CA125 Ovarian Cancer AntigenJournal of Biological Chemistry, 2001
- The CA 125 Gene: An Extracellular Superstructure Dominated by Repeat SequencesTumor Biology, 2001
- Tissue Quantification of CA 125 in Epithelial Ovarian CancerThe International Journal of Biological Markers, 1999
- Reactivity of a monoclonal antibody with human ovarian carcinoma.Journal of Clinical Investigation, 1981